2.12 USD
↗ 0.10 (4.95%)AT CLOSE (03:59 PM EST)
Atossa Therapeutics, Inc. Common Stock
ATOSNASDAQ • USD
2.13
↗ 0.01 (0.66%)
POST MARKET (AS OF 04:00 PM EST)
Post Market
AS OF 04:00 PM EST
2.13
↗ 0.01 (0.66%)
Market: CLOSED
ATOS is currently priced at $2.12. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 6, 2026.
Open?$1.99
High?$2.19
Low?$1.99
Prev. Close?$2.02
Volume?34.8K
Avg. Volume?88.2K
VWAP?$2.10
Rel. Volume?0.39x
Bid / Ask
Bid?$1.78 × 100
Ask?$2.44 × 100
Spread?$0.66
Midpoint?$2.11
Valuation & Ratios
Market Cap?21.2M
Shares Out?10.0M
Float?8.9M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?0.79
EPS?-$3.78
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Themes
Employees
14
Market Cap
21.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-11-08
Address
1448 NW MARKET STREET
SEATTLE, WA 98107
Phone: 206.588.0256
SEATTLE, WA 98107
Phone: 206.588.0256
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?65
Piotroski F-Score?0/9Weak
Altman Z-Score?-12.21Distress
Confidence?49%Low
Short InterestHigh
Short % of Float?7.68%Elevated
Short Interest?683.5K
Days to Cover?5.9
Free Float8.9M
Avg Daily Volume116.9K
Settlement Date2026-10-15
Financial Health
Current Ratio?5.69Strong
Quick Ratio?5.14Strong
Cash Ratio?4.79Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.79CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.1CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-140.6%WEAK▾
S&P3
ROA?-116.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-35783000
Enterprise Value?$-4937888
Fundamentals ratios updated end of day